Autoantibodies could shape cancer risk, growth and response to immunotherapy

Autoantibodies could shape cancer risk, growth and response to immunotherapy. Scientists have long sought to understand why some people with no known risk factors develop cancer while others with significant risk never do.

A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.

Trechos de apoio da pauta: Scientists have long sought to understand why some people with no known risk factors develop cancer while others with significant risk never do. The answer may lie in immune proteins known as autoantibodies (auto-Abs), suggests a commentary published in Cell co-authored by a team that includes Jean-Laurent Casanova, M.D., Ph.D., a professor in the Center for the Genetics of Host Defense and Children's Medical Center Research Institute at UT Southwestern (CRI).

• Ponto de atenção: autoantibodies.
• Ponto de atenção: could.
• Ponto de atenção: shape.

Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.